Compounds > isoxazoles
Page last updated: 2024-08-21

isoxazoles and Infections, Respiratory Syncytial Virus

isoxazoles has been researched along with Infections, Respiratory Syncytial Virus in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (66.67)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bao, X; Chen, Y; Choi, EJ; Garofalo, RP; Liu, S; Ren, J; Ren, Y; Wang, P; Wu, W; Zhou, J1
Dunn, MC; Knight, DA; Waldman, WJ1
Chen, FP; Davis, IC; Fortenberry, JA; Graves, LM; Hickman-Davis, JM; Lazarowski, ER; Matalon, S; Sorscher, E; Sullender, WM; Zhao, X1
Doi, T; Kato, T; Nikaido, K; Takayama, R1
Chen, FP; Davis, IC; Hickman-Davis, JM; Lazarowski, ER; Matalon, S; Sullender, WM1
Moore, ML; Peebles, RS1

Other Studies

6 other study(ies) available for isoxazoles and Infections, Respiratory Syncytial Virus

ArticleYear
Exchange Proteins Directly Activated by cAMP and Their Roles in Respiratory Syncytial Virus Infection.
    Journal of virology, 2018, 11-15, Volume: 92, Issue:22

    Topics: A549 Cells; Animals; Cell Line; Chemokines; Cyclic AMP-Dependent Protein Kinases; Guanine Nucleotide Exchange Factors; Humans; Hydrazones; Isoquinolines; Isoxazoles; Mice; NF-kappa B; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; RNA Interference; RNA, Small Interfering; Sulfonamides; Virus Replication

2018
Inhibition of respiratory syncytial virus in vitro and in vivo by the immunosuppressive agent leflunomide.
    Antiviral therapy, 2011, Volume: 16, Issue:3

    Topics: Animals; Antiviral Agents; Bronchi; Cell Line, Tumor; Cytopathogenic Effect, Viral; Dose-Response Relationship, Drug; Epithelial Cells; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Sigmodontinae; Treatment Outcome; Viral Load

2011
Leflunomide prevents alveolar fluid clearance inhibition by respiratory syncytial virus.
    American journal of respiratory and critical care medicine, 2006, Mar-15, Volume: 173, Issue:6

    Topics: Animals; Antiviral Agents; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Disease Progression; Female; Isoxazoles; Leflunomide; Lung; Male; Mice; Mice, Inbred BALB C; Nucleotidases; Pneumonia, Viral; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Severity of Illness Index

2006
[Valproate sodium and zonisamide associated interstitial pneumonitis in an infant].
    No to hattatsu = Brain and development, 2007, Volume: 39, Issue:1

    Topics: Anticonvulsants; Epilepsy; Female; Humans; Infant; Isoxazoles; Lung Diseases, Interstitial; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Spasms, Infantile; Valproic Acid; Zonisamide

2007
Post-infection A77-1726 blocks pathophysiologic sequelae of respiratory syncytial virus infection.
    American journal of respiratory cell and molecular biology, 2007, Volume: 37, Issue:4

    Topics: Administration, Intranasal; Airway Resistance; Aniline Compounds; Animals; Antiviral Agents; Bronchoalveolar Lavage Fluid; Cell Count; Chemokines; Crotonates; Dimethyl Sulfoxide; DNA; Drug Administration Schedule; Extravascular Lung Water; Hydroxybutyrates; Isoxazoles; Leflunomide; Lung; Mice; Mice, Inbred BALB C; Nitriles; Oxygen; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Toluidines; Virus Replication

2007
A mechanistic advance in understanding RSV pathogenesis, but still a long way from therapy.
    American journal of respiratory cell and molecular biology, 2007, Volume: 37, Issue:4

    Topics: Aged; Airway Obstruction; Animals; Antibodies, Viral; Antiviral Agents; Cattle; Humans; Infant; Isoxazoles; Leflunomide; Mice; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses

2007